Dr. Paras N. Prasad was born in 1946 in Bihar (India). In 1966, he obtained an MSc. from Bihar University (India) and in 1971 a Ph.D. at the University of Pennsylvania (U.S.A.). As a postdoctoral Fellow, he worked at the University of Michigan from 1971 to 1974. He is a Distinguished Professor of Chemistry, Physics, Medicine, and Electrical Engineering, the highest rank in the New York State University system. He also holds the Samuel P. Capen Chair at the University at Buffalo, and since 1999, he has been the Executive Director of the multidisciplinary Institute for Lasers, Photonics and Biophotonics. His Multidisciplinary research is in the field of photonics and nonlinear optics. He has received much recognition (honorary doctorates, fellowships, medals) for his pioneering contributions. He received Scientific American’s Top 50 (2005); he is a Fellow of the American Physical Society, a Fellow of the Optical Society of America, and National Academy of Inventors (2016). For his pioneering work on “Nanoclinics” for Biophotonics, he was also awarded the Technology/Discovery award from the Western New York Health Care Industries Association. He received an honorary doctorate from the Royal Institute of Technology in Sweden (KTH) for his pioneering work in areas including the use of light-based technologies to address important, global health problems.
Dr. Paras N. Prasad was born in 1946 in Bihar (India). In 1966, he obtained an MSc. from Bihar University (India) and in 1971 a Ph.D. at the University of Pennsylvania (U.S.A.). As a postdoctoral Fellow, he worked at the University of Michigan from 1971 to 1974. He is a Distinguished Professor of Chemistry, Physics, Medicine, and Electrical Engineering, the highest rank in the New York State University system. He also holds the Samuel P. Capen Chair at the University at Buffalo, and since 1999, he has been the Executive Director of the multidisciplinary Institute for Lasers, Photonics and Biophotonics. His Multidisciplinary research is in the field of photonics and nonlinear optics. He has received much recognition (honorary doctorates, fellowships, medals) for his pioneering contributions. He received Scientific American’s Top 50 (2005); he is a Fellow of the American Physical Society, a Fellow of the Optical Society of America, and National Academy of Inventors (2016). For his pioneering work on “Nanoclinics” for Biophotonics, he was also awarded the Technology/Discovery award from the Western New York Health Care Industries Association. He received an honorary doctorate from the Royal Institute of Technology in Sweden (KTH) for his pioneering work in areas including the use of light-based technologies to address important, global health problems.